JP2002539089A - 成長ホルモン分泌促進薬 - Google Patents
成長ホルモン分泌促進薬Info
- Publication number
- JP2002539089A JP2002539089A JP2000599774A JP2000599774A JP2002539089A JP 2002539089 A JP2002539089 A JP 2002539089A JP 2000599774 A JP2000599774 A JP 2000599774A JP 2000599774 A JP2000599774 A JP 2000599774A JP 2002539089 A JP2002539089 A JP 2002539089A
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- product
- preparation
- give
- embedded image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12081399P | 1999-02-19 | 1999-02-19 | |
US60/120,813 | 1999-02-19 | ||
PCT/US2000/004274 WO2000049037A1 (en) | 1999-02-19 | 2000-02-18 | Growth hormone secretagogues |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002539089A true JP2002539089A (ja) | 2002-11-19 |
JP2002539089A5 JP2002539089A5 (es) | 2007-07-05 |
Family
ID=22392709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000599774A Pending JP2002539089A (ja) | 1999-02-19 | 2000-02-18 | 成長ホルモン分泌促進薬 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1153034B1 (es) |
JP (1) | JP2002539089A (es) |
CN (1) | CN1179972C (es) |
AR (1) | AR023369A1 (es) |
AT (1) | ATE375996T1 (es) |
AU (1) | AU765642B2 (es) |
BR (1) | BR0008321A (es) |
CA (1) | CA2362303A1 (es) |
CO (1) | CO5160260A1 (es) |
DE (1) | DE60036785D1 (es) |
IL (1) | IL144350A0 (es) |
PE (1) | PE20001468A1 (es) |
WO (1) | WO2000049037A1 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6639076B1 (en) | 1998-08-18 | 2003-10-28 | Eli Lilly And Company | Growth hormone secretagogues |
US6828331B1 (en) | 1999-02-19 | 2004-12-07 | Eli Lilly And Company | Growth hormone secretagogues |
AU2001264977B2 (en) | 2000-05-30 | 2005-04-14 | Merck & Co., Inc. | Melanocortin receptor agonists |
US6756385B2 (en) * | 2000-07-31 | 2004-06-29 | Pfizer Inc. | Imidazole derivatives |
GT200100147A (es) * | 2000-07-31 | 2002-06-25 | Derivados de imidazol | |
WO2002032878A1 (en) * | 2000-10-13 | 2002-04-25 | Eli Lilly And Company | Resolution process for preparation of substantially pure (r) and (s) enantiomers of 2-(4-nitroimidazolyl)-4-methoxyphenylpropionic acid and salts thereof |
KR100593510B1 (ko) * | 2001-01-23 | 2006-06-28 | 가도르 에스.에이. | 골의 대사성 질병의 예방 및/또는 치료를 위한비스포스포네이트 함유 조성물, 그 조성물의 제조방법 및그의 이용 |
US7125840B2 (en) | 2001-10-09 | 2006-10-24 | Eli Lilly And Company | Substituted dipeptides as growth hormone secretagogues |
ES2271557T3 (es) | 2002-04-09 | 2007-04-16 | Eli Lilly And Company | Secretagogos dipeptidicos de la hormona del crecimiento. |
RS50595B (sr) * | 2004-03-23 | 2010-05-07 | Pfizer Products Incorporated | Jedinjenja imidazola za lečenje neurodegenerativnih poremećaja |
EP1940802A2 (en) | 2005-09-22 | 2008-07-09 | Pfizer Products Inc. | Imidazole compounds for the treatment of neurological disorders |
US10590087B1 (en) | 2019-08-09 | 2020-03-17 | Pfizer Inc. | Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof |
US11884634B2 (en) | 2019-08-09 | 2024-01-30 | Pfizer Inc. | Compositions of solid forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4- tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide |
US11504354B1 (en) | 2021-09-08 | 2022-11-22 | SpringWorks Therapeutics Inc.. | Chlorinated tetralin compounds and pharmaceutical compositions |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL107836A (en) * | 1992-12-11 | 1998-01-04 | Merck & Co Inc | Spiro piperidines and homologues, their preparation and pharmaceutical preparations containing them |
SK282166B6 (sk) * | 1992-12-11 | 2001-11-06 | Merck & Co., Inc. | Spiropiperidínové deriváty, spôsob ich výroby a farmaceutický prostriedok s ich obsahom |
US5721250A (en) * | 1993-12-23 | 1998-02-24 | Merck & Co. Inc. | Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
WO1998016527A1 (en) * | 1996-10-15 | 1998-04-23 | Fujisawa Pharmaceutical Co., Ltd. | Benzoxepine derivatives which promote release of growth hormone |
ZA987385B (en) * | 1997-08-19 | 2000-04-18 | Lilly Co Eli | Growth hormone secretagogues. |
ZA987383B (en) * | 1997-08-19 | 2000-02-17 | Lilly Co Eli | Treatment of congestive heart failure with growth hormone secretagogues. |
-
2000
- 2000-02-17 CO CO00011043A patent/CO5160260A1/es unknown
- 2000-02-18 PE PE2000000127A patent/PE20001468A1/es not_active Application Discontinuation
- 2000-02-18 IL IL14435000A patent/IL144350A0/xx unknown
- 2000-02-18 CN CNB008037035A patent/CN1179972C/zh not_active Expired - Fee Related
- 2000-02-18 DE DE60036785T patent/DE60036785D1/de not_active Expired - Lifetime
- 2000-02-18 WO PCT/US2000/004274 patent/WO2000049037A1/en active IP Right Grant
- 2000-02-18 BR BR0008321-6A patent/BR0008321A/pt not_active IP Right Cessation
- 2000-02-18 AT AT00913536T patent/ATE375996T1/de not_active IP Right Cessation
- 2000-02-18 JP JP2000599774A patent/JP2002539089A/ja active Pending
- 2000-02-18 AU AU34968/00A patent/AU765642B2/en not_active Ceased
- 2000-02-18 EP EP00913536A patent/EP1153034B1/en not_active Expired - Lifetime
- 2000-02-18 CA CA002362303A patent/CA2362303A1/en not_active Abandoned
- 2000-02-18 AR ARP000100708A patent/AR023369A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CO5160260A1 (es) | 2002-05-30 |
DE60036785D1 (de) | 2007-11-29 |
CN1347420A (zh) | 2002-05-01 |
AU765642B2 (en) | 2003-09-25 |
IL144350A0 (en) | 2002-05-23 |
AR023369A1 (es) | 2002-09-04 |
EP1153034A1 (en) | 2001-11-14 |
CN1179972C (zh) | 2004-12-15 |
BR0008321A (pt) | 2002-01-29 |
AU3496800A (en) | 2000-09-04 |
ATE375996T1 (de) | 2007-11-15 |
EP1153034B1 (en) | 2007-10-17 |
CA2362303A1 (en) | 2000-08-24 |
WO2000049037A1 (en) | 2000-08-24 |
PE20001468A1 (es) | 2000-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1326851B1 (en) | Substituted dipeptides as growth hormone secretagogues | |
US5773441A (en) | 2-acylaminopropanamides as growth hormone secretagogues | |
US6639076B1 (en) | Growth hormone secretagogues | |
TW577879B (en) | Novel compounds exhibiting growth hormone secretagogue activity, pharmaceutical composition containing the same and their uses | |
EP0898963A2 (en) | Congestive heart failure treatment | |
JP2002539089A (ja) | 成長ホルモン分泌促進薬 | |
US6329342B1 (en) | Treatment of congestive heart failure with growth hormone secretagogues | |
WO1997007117A1 (en) | 2-acylaminopropanamines as growth hormone secretagogues | |
EP1497317B1 (en) | Dipeptidic growth hormone secretagogues | |
US6828331B1 (en) | Growth hormone secretagogues | |
US7125840B2 (en) | Substituted dipeptides as growth hormone secretagogues | |
EP1112071A1 (en) | Growth hormone secretagogues | |
CA2340344A1 (en) | Growth hormone secretagogues | |
MXPA01008309A (es) | Secretagogos de la hormona de crecimiento | |
JP2002523368A (ja) | 成長ホルモン分泌促進薬 | |
US20060167268A1 (en) | Growth hormone secretagogues | |
CZ2000596A3 (cs) | Sekretagogy růstového hormonu, způsob jejich přípravy a farmaceutický prostředek s jejich obsahem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070216 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070216 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070413 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100309 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100803 |